Terapia Respiratoria
Permanent URI for this collection
Browse
Browsing Terapia Respiratoria by Subject "Administración de heliox"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item “Caracteristicas de la administracion del heliox en pacientes diagnosticados con bronquiolitis. Revisión rápida de la literatura.”(Universidad Santiago de Cali, 2021) Bolaños Muñoz Luissa Fernanda; Del Pezo Varela Margarita Rosa; Florez Acevedo, Stephany Julieth; Monsalve García, AdrianaIntroduction: "Bronchiolitis is a respiratory disease of viral origin that especially affects the pediatric population <2 years of age, with an annual incidence of 10% worldwide"1,2 It causes a demand for care in primary care between 4-20% and in hospital emergency departments between 0.8-2.5%. "Studies and authors affirm that the treatment of this disease is varied"3. For some decades now, the "benefits of the use and administration of heliox for patients with upper and lower airway complications who do not respond or show improvement to conventional treatment "4 have been described; however, there is no consensus regarding the use of this therapy and its form of administration. Objective: Review the characteristics of heliox administration in patients <2 years old with a diagnosis of bronchiolitis based on scientific evidence. Methodology: A rapid review of the literature produced between January 2015 and June 2021, in Spanish, English and Portuguese languages was performed. Inclusion and exclusion criteria were established, in which the characteristics of heliox administration in patients <2 years with a diagnosis of bronchiolitis were analyzed. The search was executed in the bibliographic search engines PubMed, Sciencedirect, Dialnet and National library of medicine. The terms considered for the search were "bronchiolitis" and "heliox". The quality of the selected articles was verified using the PEDro scale and two qualitative matrices were constructed for data analysis. Results: Eighteen articles were initially identified for analysis, of which two articles were selected for the final review. The selected studies had a PEDro 8/11 scale and evidenced two forms of heliox administration with low flow and high flow systems for the management of patients <2 years with bronchiolitis. Conclusion: There is not enough scientific evidence regarding the forms of heliox administration in patients with bronchiolitis, however, this rapid literature review allowed us to identify that the administration of this gas has a better clinical outcome in cases where heliox is administered with high flow systems